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Abstract.  Glycophosphatidylinositol (GPI)-anchored 
membrane proteins are initially  synthesized with a 
cleavable COOH-terminal extension that signals an- 
chor attachment.  Overexpression in COS cells of 
hGH-DAF fusion proteins containing  the GPI signal of 
decay accelerating factor (DAF) fused to the COOH- 
terminus  of human growth hormone (hGH), produces 
both GPI-anchored hGH-DAF and uncleaved precur- 
sors that retain the GPI signal.  Using hGH-DAF fu- 
sion proteins containing  a mutated,  noncleavable GPI 
signal,  we show that uncleaved polypeptides are re- 
tained inside the cell and accumulate in a brefeldin 
A-sensitive, Golgi-like juxtanuclear structure.  Reten- 
tion requires the presence of either a functional or a 
noncleavable GPI signal;  hGH-DAF fusion proteins 
containing only the COOH-terminal hydrophobic do- 
main (a component of the GPI signal) are secreted. 
Immunofluorescence analysis shows colocalization of 
the retained,  uncleaved fusion proteins with both a 
Golgi marker and with p53, a marker of the ER-Golgi 
intermediate compartment.  Since N-linked glycosyla- 
tion is postulated to facilitate the transport of proteins 
to the cell surface,  we engineered a glycosylation site 
into hGH-DAE  Glycosylation failed to completely 
override the transport block, but allowed some un- 
cleaved hGH-DAF to pass through the secretory path- 
way and acquire endoglycosidase H  resistance.  The 
retained molecules remained endoglycosidase H  sensi- 
tive. We suggest that the uncleaved fusion protein is 
retained in a  sorting compartment between the ER and 
the medial Golgi complex. We speculate that a mecha- 
nism exists to retain proteins containing an uncleaved 
GPI signal as part of a  system for quality control. 
small but diverse class of cell surface proteins is now 
known to be anchored to the plasma membrane by 
a  glycophosphatidylinositol  (GPI) ~ structure cova- 
lently attached to the COOH terminus of the protein (Cross, 
1990; Low, 1989; Ferguson and Williams,  1988). The GPI 
membrane anchor contains ethanolamine,  carbohydrate,  and 
phosphatidylinositol  (Ferguson et al.,  1988), and is appar- 
ently preassembled in the ER by sequential glycosylation of 
phosphatidylinositol  (Masterson et al.,  1989).  GPI attach- 
ment to protein requires translocation  of the protein across 
the membrane of the RER; proteins that lack a signal peptide 
fail to become GPI-anchored (Caras,  1991). Attachment  is 
presumed to occur at the luminal  side of the ER, following 
which the GPI-anchored protein is transported to the cell 
surface via the Golgi apparatus.  GPI-anchored proteins are 
initially synthesized with a cleavable signal at the COOH ter- 
minus (Boothroyd et al., 1981; Tse et al., 1985; Caras et al., 
1987). GPI-attachment, directed by this signal,  occurs in a 
coordinated  processing  event  in  which  17-31 COOH-ter- 
minal residues are proteolytically removed, and the GPI an- 
1. Abbreviations used in this paper: BFA, brefeldin A; CGN, cis-Gotgi net- 
work;  COS,  African green monkey CV-1 cells constitutively  expressing 
SV40 T-antigen; DAF, decay accelerating factor; GPI, glycophosphatidyl- 
inositol; hGH, human growth hormone;  PDI, protein disulfide isomerase; 
rGH, rat growth hormone. 
chor is then attached to the new COOH terminus.  The pro- 
cessing enzyme(s), possibly a transamidase,  has not yet been 
identified. 
We have used the GPI-anchored protein, decay accelerat- 
ing factor (DAF), as a model system to study the signal for 
anchor attachment.  The last 29 to 37 amino acids of DAF, 
when fused to the COOH terminus  of a normally secreted 
protein,  human  growth  hormone  (hGH),  will  target  the 
resulting hGH-DAF fusion protein to the plasma membrane 
by means ofa GPI anchor (Caras et al., 1987; Moran et al., 
1991).  Further  analysis  of this  COOH-terminal  DAF  se- 
quence indicates that the GPI signal contains two critical fea- 
tures:  a COOH-terminal hydrophobic  domain  (17 residues) 
and a cleavage/attachment  site for anchor addition.  The lat- 
ter is comprised of a pair of small residues,  optimally posi- 
tioned 10 to 12 residues NH2-terminal  to the hydrophobic 
domain (Caras et al.,  1989; Moran and Caras,  1991). The 
DAF GPI signal  is cleaved at a Ser-Gly sequence (Fig.  1) 
(Moran et al., 199t) releasing a 28-residue COOH-terminal 
peptide that includes the hydrophobic  domain.  Small  resi- 
dues that function well at the attachment site include Ser, 
Gly, Ala, Asp, Asn, and possibly Cys (Moran et al.,  1991; 
Micanovic et al., 1990). Substitution of one or both residues 
surrounding  the cleavage/attachment  site with  a  large  or 
bulky residue,  abolishes both cleavage and anchor attach- 
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Figure 1.  Schematic  diagram  showing  the  COOH-terminal  se- 
quences  of the  hGH-DAF  fusion  proteins.  The  fusion proteins 
shown contain the COOH-terminal 37-, 29-, 28-, or I7-residues of 
DAF as indicated  (large type), fused to the  COOH-terminus of 
hGH (small type) (Moran et al.,  1991; Caras et al., 1989).  The 17- 
residue COOH-terminal hydrophobic domain, a critical component 
of the GPI signal (Caras et al.,  1989),  is indicated by a black box. 
The cleavage site is denoted by an arrow and the anchor addition 
site,  Ser319 of DAF (Moran et al.,  1991),  is underlined. 
ment (Moran et al.,  1991; Moran and Caras,  1991). The un- 
cleaved fusion proteins are not transported  to the cell  sur- 
face, but inside accumulate inside the cell. In addition, when 
hGH-DAF fusion proteins containing  a  functional GPI sig- 
nal  are overexpressed  in  COS  cells,  processing  is  incom- 
plete, leading to significant accumulation of both uncleaved 
as well  as GPI-linked  forms of the  protein  (Moran  et al., 
1991).  Whereas  GPI-linked  hGH  is  transported  to  the 
plasma membrane via the secretory pathway, the uncleaved 
fusion protein remains trapped  inside the cell. 
In this report we studied the fate of hGH-DAF fusion pro- 
teins bearing an uncleaved GPI signal. We describe experi- 
ments designed  to ask where in the secretory pathway the 
transport block occurs.  We also studied the effect of intro- 
ducing a glycosylation site into the normally unglycosylated 
hGH  backbone.  The  rationale  for  this  was  twofold:  first, 
analysis of N-linked carbohydrate can determine whether a 
protein has traversed the Golgi apparatus;  and second,  be- 
cause N-linked glycosylation has been shown to facilitate the 
transport of some proteins to the cell surface (Guan et al., 
1985; Machamer et al.,  1985), we asked whether glycosyla- 
tion could reverse the retention of hGH-DAF proteins con- 
taining an uncleaved GPI signal.  We speculate that the un- 
cleaved  GPI signal  acts as a  retention  signal  that prevents 
transport  to the cell  surface,  possibly as a  form of quality 
control. 
Recombinant Plasmids and Fusion Proteins 
Plasmids encoding hGH-DAF37, hGH-DAF29 and hGH-DAF28 have been 
previously described (Moran et al., 1991). To produce glycosylated forms 
of  these fusion proteins, oligonucleotide-directed  mutngenesis (McClary et 
at., 1989) was used to introduce a consensus sequence for N-linked glycosy- 
lation (Asn-X-Ser/Thr). To produce fusion proteins glycosylated at ASh-63 
in the hGH sequence (proteins designated gly63), Glu-65 was mutated to 
Ser-65; a second mutation introduced a glycosylation site at position 98 in 
the hGH sequence (proteins designated gly98) by the conversion of Ala-98 
to Asn-98. DNA manipulation was then used to transfer these mutations to 
hGH-DAF37, hGH-DAF29 and hGH-DAF28, to produce a gly63- and a 
gly98-form of each fusion protein. The recombinant DNAs were cloned 
into a  mammalian expression vector containing a  cytomegalovirus en- 
hancer/promoter as previously described (Caras et aI.,  1989). 
Transfections, Metabolic Labeling, 
and lmmunoprecipitation 
COS cells were transfected using the DEAE dextran method as described 
by Selden (1987) using 2 ~g of plasmid DNA per 35-mm dish and DEAE- 
dextran at 400 #g/ml. Metabolic labeling of ceils with [35S]methionine was 
as previously described (Caras et al.,  1989).  The cells were harvested by 
scraping and lysed with 1% NP-40 in the presence of a protease inhibitor 
(1 mm PMSF). Immunoprecipitations were carried out as described by An- 
derson and Blobel (1983). 
Pulse-Chase Experiments 
Transfected cells in 6-well dishes were incubated in methionine-free Dul- 
Materials and Methods 
Antibodies 
Mouse monoclonal antibody O1/93  against the intermediate compartment 
marker, p53 (Schweizer et ai., 1988,  1991), was generously provided by Dr. 
H.-P. Hauri (University of Basel, Basel, Switzerland); mouse monoclonal 
antibody, 5D3, against the 72-kD KDEL receptor (Vaux et al., 1990)  was 
from Dr. D. Vaux (European Molecular Biology Laboratory, Heidelberg, 
Germany);  a  rabbit  antibody  against  protein  disulfide  isomerase  was 
provided by R. Freedman (University of Canterbury, UK); the anti-Golgi 
complex mouse monoclonal antibody, recognizing  a 52-kD protein purified 
from an isolated Golgi fraction from a human breast carcinoma, was from 
Upstate Biotechnology (lake Placid, NY; catalogue no. 05-137);  Affinity- 
purified rabbit antibody against hGH was supplied by the Medicinal and An- 
alytical Chemistry Department at Genentech, Inc. (South San Francisco, 
CA); fluorescent anti-mouse or anti-rabbit IgG was from Cappet Laborato- 
ries (Cochranville, PA). Rhodamine-conjugated  wheat germ agglutinin was 
from Molecular Probes, Inc. (Eugene, OR). 
Figure 2. (a) Lack of a precursor-product relationship between un- 
cleaved hGH-DAF polypeptides and GPI-linked molecules. Trans- 
fected COS cells were pulse labeled with [35Slmethionine  for 25 
min,  washed,  and  then  chased  from  1  to 24  h  as described  in 
Materials and Methods. Cell lysates were immunoprecipitated with 
a purified goat anti-hGH antibody and subjected to SDS-PAGE on 
a  15 % acrylamide gel. The radioactive bands were visualized by 
autoradiography. The processed GPI-linked forms of hGH-DAF37 
and hGH-DAF29 migrate faster than the corresponding uncleaved 
fusion proteins (Moran et al., 1991). Additional faint lower molecu- 
lar weight bands might represent degradation products of  the fusion 
proteins. (b) Degradation of GPI-linked and uncleaved hGH-DAF 
fusion proteins. The radioactive bands shown in a were quantitated 
directly from the dried gel using a Fuji BAS2000 Bio-Imaging an- 
alyzer. The amount of each fusion protein remaining during the 
chase was normalized to the amount present directly after the pulse. 
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of hGH-DAF fusion  proteins con- 
taining  a noncleavable  GPI signal. 
Four different fusion proteins are 
shown to indicate the generality 
of the staining pattern observed. 
COS cells were transiently trans- 
fected  with  DNAs  encoding an 
hGH-DAF fusion protein with a 
defective,  noncleavable GPI sig- 
nal; these proteins contain non- 
permissible residues at the posi- 
tion  of the  cleavage/attachment 
site. Cells were fixed, permeabil- 
ized  and  stained  with  an  anti- 
hGH antibody  as described in  Ma- 
terials and Methods.  (A) Fusion 
protein  HLD.S12F  (Moran  and 
Caras,  1991)  containing the  se- 
quence Ser-Phe at the cleavage/ 
attachment  site;  (B)  HLD.S ~2 
(Moran and Caras, 1991), contain- 
ing Ser-Glu at the cleavage site; 
(C)  hGH-DAF29-Val (Moran et 
al.,  1991),  containing Val-Gly at 
the cleavage site; (D) hGH-DAF28, 
containing Phe-Gly at the cleav- 
age site (Moran et al., I991). We 
have previously determined that 
none  of  these proteins are secreted. 
(b) Double label immunolocaliza- 
tion of hGH-DAF28 and protein 
disulfide isomerase (PDI). Trans- 
letted COS cells grown on cover- 
slips were fixed and permeabilized 
and incubated with a mouse mono- 
elonal antibody against hGH and 
a  rabbit antibody against bovine 
PDI. The cells were then washed 
and treated with fluorescein-con- 
jugated anti-rabbit  and rhodamine- 
conjugated anti-mouse IgG. 
becco's minimal  essential medium (DMEM) for 15 rain and then pulsed for 
20-25 rain with [3~S]methionine  (125 ~Ci per well; >1,000 Ci/mmol) in 
methionine-free DMEM. The cells were then washed and chased with com- 
plete medium for up to 24 h and analyzed by immunoprecipitation. 
Endoglycosidase H and Neuraminidase Digestions 
Immunopreeipitated proteins bound to protein A, were resuspended in 40 
t~l of 0.05 M sodium phosphate buffer, pH 6, containing either 0.02 units 
of endo H (Genzyme or Genencor, S. San Francisco, CA) or 0.01 units of 
neuraminidase (Genzyme Corp., Cambridge, MA) and incubated at 37"C 
overnight. The digested samples were then washed once with 0.05 M so- 
dium phosphate buffer, pH 6, and subjected to SDS-PAGE.  The radioactive 
bands were visualized by autoradiography at -70"C using an intensifying 
screen. The radioactive bands were quantitated directly from the dried gel 
using a Fuji BAS2000 Bio-Imaging analyzer (Fuji, Stamford, CT). 
Immunofluorescent Labeling 
Immunofluorescent labeling of intact cells (cell surface labeling) or permea- 
bilized cells  (internal labeling) was carried  out essentially as described 
(Caras et al., 1989) except that 0.5 % Triton X-100/PBS  was used to permea- 
bilize the cells. Cells were incubated with a purified rabbit antibody against 
hGH, followed by fluorescein-conjugated goat anti-rabbit antiserum (Cap- 
pel Laboratories). 
Results 
We have studied the expression in COS cells of chimeric pro- 
teins containing a  GPI signal from the COOH-terminus of 
DAF,  fused  to  the  COOH-terminus  of hGH,  a  normally 
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chased for various times. Cell lysates were analyzed by im- 
munoprecipitation (Fig. 2 a).  Both the GPI-linked species 
and the uncleaved protein were present in the cell lysates im- 
mediately after the pulse, and there was no evidence of any 
precursor-product  relationship  between  the  two  species. 
Both proteins disappeared from the cells with similar ki- 
netics (Fig. 2 b), and the uncleaved protein could be detected 
in the cell lysates for up to 24 h after the chase, indicating 
that this species is a terminal product of  the cells rather than 
a newly synthesized intermediate. 
We have previously shown that substitutions at the cleav- 
age-attachment site of the GPI-signal abolish both cleavage 
and anchor attachment (Moran et al.,  1991).  For example, 
cells expressing the noncleavable fusion protein hGH-DAF- 
28 (containing Phe in place of  Ser at the cleavage-attachment 
site of the GPI-signal [Fig.  1]), produce only the larger un- 
cleaved protein product (Fig. 2 a), which disappeared from 
the cells with the same kinetics as the uncleared forms of 
hGH-DAF37 and hGH-DAF29 (Fig.  2  b).  The uncleaved 
hGH-DAF28 fusion protein was not present on the cell sur- 
face (Moran et al.,  1991) and only trace amounts could be 
detected in the cell media, suggesting that the protein does 
not traverse the secretory pathway,  but instead is degraded 
inside the cells.  The half-life was 3  to 4  h  for both hGH- 
DAF28 and the uncleaved forms of hGH-DAF37 and hGH- 
DAF29, and "~3 h for the GPI-anchored forms of hGH-DAF- 
37 and hGH-DAF29. 
Figure 4. (a) Double label immunolocalization of  hGH-DAF28 and 
a Golgi marker (upper); and hGH-DAF28 and wheat germ aggluti- 
nin (lower), Transfected COS ceils were treated as follows: upper 
panels, ceils were fixed and permeabilized and incubated with rab- 
bit anti-hGH  IgG and a mouse monoclonal antibody against the 
C-olgi  apparatus, followed  by ftuorescein-conjugated  anti-rabbit and 
rhodamine-conjugated anti-mouse IgG; (lower)  cells were fixed  and 
incubated with wheat germ agglutinin (2 mg/ml in PBS) for 60 min 
at room temperature to saturate cell surface binding sites. The ceils 
were then permeabilized and incubated with rhodamine-conjugated 
wheat germ agglutinin, followed by rabbit anti-hGH IgG, followed 
by fluorescein-conjugated anti-rabbit  IgG.  (b) Double label im- 
munoloealization of hGH-DAF28 and a Golgi marker before and 
after treatment  with brefeldin A (BFA). 24 h after transfection, 
COS cells were treated with 10/~g/ml BFA for 2 h as indicated. 
Ceils were fixed and permeabilized and incubated with rabbit anti- 
hGH IgG  and a  mouse monoctonal antibody against the Golgi 
apparatus, followed by fluorescein-conjugated anti-rabbit and rho- 
damine-conjugated anti-mouse IgG. The Golgi marker recognizes 
a 52-kD protein purified from an isolated Golgi fraction from a hu- 
man breast carcinoma (Upstate Biotechnology). Both punctate and 
diffuse  staining  was  observed  after treatment  with  BFA, often 
within the same cell. 
secreted  protein.  As  previously  reported  (Moran  et  at., 
1991), ceils expressing the fusion proteins hGH-DAb37 and 
hGH-DAF29 (Fig.  1), both of which contain a  functional 
GPI-signal, produce two products precipitable with an anti- 
hGH antibody: a lower molecular weight GPI-linked form 
that is transported to the cell surface, and a larger uncleaved 
form that is not GPI-linked, but retains the GPI-signal. To 
determine whether the uncleaved protein is a newly synthe- 
sized precursor to the OPI-linked form, we performed a se- 
ries of pulse-chase experiments. 24 h after transfection, the 
Immunofluorescence Analysis 
Because cells expressing an hGH-DAF fusion protein with 
a noncleavable GPI-signal produce exclusively the uncleaved 
product which remains inside the cell, the retained protein 
can be localized without the complication of co-expression 
of a GPI-anchored, cell-surface form. Immunofluorescence 
analysis of such cells suggests that noncleavable hGH-DAF 
fusion proteins accumulate in a number of  distinct intracellu- 
lax structures (Fig. 3 a). In addition to staining of the reticu- 
lax network of the endoplasmic reticulum, we observed in- 
tense staining of a Gotgi-like juxtanuclear structure, as well 
as  of vesicular  structures  scattered  throughout the  cyto- 
plasm. Double label immunofluorescence microscopy with 
an ER marker, protein disulfide isomerase, indicated that 
this  staining  pattern  is  distinct from the diffuse reticular 
staining  seen with protein disulfide isomerase (Fig.  3  b). 
These data suggest that the uncleaved fusion proteins are re- 
tained in a post-ER compartment. Colocalization of the un- 
cleaved hGH-DAF28 fusion protein with a Golgi marker as 
well as with wheat germ agglutinin (Fig. 4  a) points to a 
Golgi localization. 
Treatment of cells with  the  drug  brefeldin A  has  been 
shown to induce rapid redistribution of Golgi proteins into 
the  ER  (Lippincott-Schw~  et  al.,  1989).  We  therefore 
tested whether the juxtanuctear accumulation of  hGH-DAF- 
28 is affected by exposure of the cells to brefeldin A. In the 
presence of brefeldin A both the hGH-DAF28 fusion protein 
and the Golgi marker redistributed to a diffuse staining pat- 
tern (Fig. 4 b). Upon removal of the drug, both markers re- 
sumed their original juxtanuclear position (not shown). We 
concluded that the noncleavable hGH-DAF28 fusion protein 
accumulates in a brefeldin A-sensitive intracellular compart- 
ment, possibly the Golgi apparatus. 
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cosylation. COS cells were transfected with DNAs encoding hGH-DAF fusion proteins as indicated, containing a potential glycosylation 
site at position 63 (gly63) or 98 (gly98) as indicated. 24 h after transfection the cells were labeled with [35S]methionine  (166 #Ci per 35 
mm well) for 6 h. Immunoprecipitates of the cell lysates were divided in two equal portions and incubated overnight in the presence (+) 
or absence (-) of endo H as described in Materials and Methods, before being subjected to SDS-PAGE. The unglycosylated form of each 
fusion protein is included for reference (lanes 1, 6, and 11). Band assignments are as follows: GPIL, GPI-linked; UC, uncleaved; G, 
glycosylated; UG, unglycosylated. The positions of the glycosylated forms of uncleaved hGH-DAF37 and hGH-DAF29 (UC, G) can be 
determined by reference to the glycosylated form of hGH-DAF28. The glycosylated GPI-linked species (GPIL, G) are presumably repre- 
sented by the broad smeared bands visible in lanes 2 to 5 and 7 to 10. 
Analysis of Glycosylated Forms of GPI-Linked and 
Uncleaved hGH-DAF Fusion Proteins 
Localization of a protein within the Golgi complex can in 
some instances be confirmed by biochemical analysis of the 
N-linked carbohydrate. Conversion from endoglycosidase H 
(endo H) sensitivity to resistance occurs in the medial Golgi 
complex (Kornfeld and Kornfeld, 1985) as a result of trim- 
ming of  the high-mannose type oligosaccharides added in the 
ER, followed by the addition of other sugars. Because hGH 
is normally unglycosylated, we used site directed mutagene- 
sis to introduce a novel glycosylation site, either at position 
63 or 98 in the amino acid sequence. In both cases, a single 
amino acid was mutated to produce a consensus sequence 
(Asn-X-Ser/Thr) for N-linked glycosylation, and DNA ma- 
nipulation was then used to create potentially glycosylated 
forms of the fusion proteins, hGH-DAF37, hGH-DAF29 and 
hGH-DAF28. 
To  determine  that  these  mutations  indeed  resulted  in 
glycosylated  products,  transiently  transfected  COS  cells 
were labeled with [3sS]methionine,  and the cell lysates were 
then analyzed by immunoprecipitation. After the introduc- 
Table L Endo H Resistance of Glycosylated hGH-DAF28, 
Determined by Quantitation of  the Bands in Fig. 5 
hGH-DAF28/Gly63  hGH-DAF28/GIy98 
-  Endo  H  + Endo  H  -  Endo  H  + Endo  H 
% 
Glycosylated  87  16  70  25 
Unglycosylated  13  84  29  75 
tion of a glycosylation site at position 63 or 98, both the GPI- 
linked (broad lower band) and the uncleaved forms (upper 
band)  of hGH-DAF37  and  hGH-DAF29  migrated  more 
slowly relative to the unglycosylated species (Fig.  5, com- 
pare lane I  with lanes 2 and 4; and lane 6 with lanes 7 and 
9).  Although  the  two  unglycosylated species  (GPI-linked 
versus uncleaved) were well separated on a  15% polyacryl- 
amide gel, the corresponding glycosylated forms appeared 
to overlap, indicating a larger mobility shift upon glycosyla- 
tion for the GPI-linked species.  This observation suggests 
that  the  GPI-linked  and  uncleaved  species  may  undergo 
differential processing  of the N-linked  carbohydrate.  The 
noncleavable hGH-DAF28 protein showed a similar shift in 
electrophoretic mobility (compare lane 11 with lanes 12 and 
14), indicating the addition of carbohydrate. 
To determine whether any or all of these glycosylated pro- 
teins had entered the medial Golgi apparatus,  we analyzed 
their sensitivity to cleavage by endo H. The uncleaved forms 
of hGH-DAF37 and hGH-DAF29 were largely endo H-sen- 
sitive; a prominent band that comigrates with the unglyco- 
sylated species reappeared after exposure to endo H (Fig. 5, 
lanes 3, 5, 8, and 10). In contrast, the GPI-linked forms of 
hGH-DAF37 and hGH-DAF29 appeared to be largely endo 
H-resistant; only trace amounts of a species corresponding 
to the unglycosylated form reappeared after treatment with 
endo H. The noncleavable fusion protein, hGH-DAF28, re- 
mained  largely  sensitive  to  endo  H.  Quantitation  of the 
bands (possible for hGH-DAF28 but not hGH-DAF37 and 
hGH-DAF29 due to overlap of the GPI-linked and unpro- 
cessed species) indicated that only 16-25 % of the molecule 
were endo  H-resistant  (Table I).  These data  suggest that 
whereas the GPI-linked molecules are transported through 
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glycosylated  hGH-DAF28. Trans- 
fected COS cells were fixed, per- 
meabilized and  stained  with  an 
anti-hGH antibody as described 
in Materials and Methods. 
the medial Golgi apparatus on their way to the cell surface, 
acquiring endo H-resistance, only a  small fraction of the 
uncleaved molecules reach the medial cisternae, where mod- 
ification of high  mannose  oligosaccharides is  believed to 
take place. We conclude from these results that the bulk of 
the uncleaved fusion protein accumulates in a compartment 
proximal to the medial Golgi compartment. Staining of cells 
expressing glycosylated hGH-DAF28 (Fig. 6) revealed a pat- 
tern indistinguishable from that seen with the unglycosylated 
fusion protein (Fig.  3).  Both species accumulate in a jux- 
tanuclear organelle, suggesting a post-ER localization. 
The Presence of  an Uncleared GPI-Signal 
Blocks Secretion 
Since it has been proposed that N-linked glycosylation may 
facilitate transport of some proteins to the cell surface (Guan 
et al.,  1985; Machamer et al.,  1985), we also examined the 
ability of the glycosylated versus unglycosylated hGH-DAF 
fusion proteins to be secreted relative to authentic hGH. 
Transfected COS  cells were labeled with  [3~S]methionine 
for 6 h, and the cell lysates and culture media were then ana- 
lyzed  by  immunoprecipitation.  During  the  6  h  labeling 
period,  66.5%  of the authentic hGH  synthesized was  se- 
creted into the medium (Fig, 7 and Table II). Fusion of the 
17-residue COOH-terminal hydrophobic domain of DAF to 
the COOH-terminus of hGH (as  in hGH-DAF17,  Fig.  1), 
slowed but did not prevent secretion; 26.5 % of the fusion 
protein appeared in the medium. In contrast, the uncleared 
form of hGH-DAF29 and  the noncleavable protein hGH- 
DAF28, were almost totally retained inside the cells. As ex- 
pected, the GPI-anchored form of hGH-DAF29,  which is 
known to be on the cell surface (Moran et al.,  1991),  re- 
mained cell associated. These results suggest that whereas 
the addition of a hydrophobic domain alone slows but does 
not block secretion of hGH, the presence of an uncleaved 
GPI signal provides a strong signal for retention. The addi- 
tion of N-linked carbohydrate resulted in secretion of a frac- 
tion (15-22%) of the hGH-DAF28 molecules synthesized, 
but failed to completely override the block to  secretion. 
Glycosylation appeared not to facilitate the secretion of un- 
processed hGH-DAF29 molecules. 
To further analyze the fate of hGH-DAF28 molecules and 
more precisely pinpoint the block in the secretory pathway, 
we carried out a pulse-chase experiment in which transfected 
COS cells were pulsed with [35S]methionine for 20 min and 
chased for 7 h. The cell lysates and culture media were then 
analyzed by immunoprecipitation following treatment with 
or without endo-H or neuraminidase (an enzyme that re- 
moves sialic acid residues added in the trans-Golgi cisternae 
[Kornfeld and Kornfeld,  1985]).  This protocol favored the 
Figure 7. Secretion of hGH and hGH-DAF fusion proteins. COS 
ceils were transfected with DNAs encoding hGH or hGH-DAF fu- 
sion proteins as indicated. After 24 h, the cells were labeled with 
[3~S]methionine (166 #Ci per 35 mm well) for 7 h and the cell ly- 
sates and culture media were analyzed by immunopreeipitation and 
SDS-PAGE. (The relative amounts of GPI-linked versus uncleared 
hGH-DAF29 varied in different experiments [compare Figs. 2 a, 
5, and 7]. The reason for this is unclear). 
Table I1. Relative Distribution of  hGH-DAF  Fusion 
Proteins in Cell Lysates and Culture Medium During a 6 h 
Labeling Period, Determined by Quantitation of  the Bands 
in Fig.  7 
Protein  Cells  Medium 
(%)  (%) 
Authentic hGH  33.5  66.5 
hGH-DAF17  73.5  26.5 
*hGH-DAF29  100.0  0 
*hGH-DAF29/Gly63  99.7  0.3 
*hGH-DAF29/Gly98  99.5  0.5 
hGH-DAF28  99.7  0.3 
hGH-DAF28/Gly63  84.3  18.7 
hGH-DAF28/GIy98  78.0  22.0 
* GPl-linked protein  plus uncleaved  polypeptide. 
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tained fractions of  glycosylated  hGH-DAF28. COS cells expressing 
either glycosylated  or unglycosylated  hGH-DAF28 (shown for ref- 
erence) as indicated, were pulsed with [3~S]methionine  for 20 min 
and then chased for 7 h. Immunoprecipitates  of the cell lysates and 
culture media were divided in equal portions and incubated over- 
night in the presence (+) or absence (-) of endo H or neuramini- 
dase, and then subjected to SDS-PAGE. We previously determined 
that the gly98, but not gly63, forms of hGH or hGHDAF acquired 
siatic acid and became neuraminidase-resistant. Neuraminidase 
digestions are therefore included for the gly98 species only. 
detection of molecules that escaped the block to secretion 
and appeared in the medium, allowing us to compare this 
secreted fraction with the fraction that was retained inside 
the cell. The secreted hGH-DAF28 protein was endo H-re- 
sistant and neuraminidase-sensitive (at position 98), indicat- 
ing passage through the Golgi Apparatus (Fig. 8). The pro- 
tein that remained inside the cell was endo H-sensitive and 
neuraminidase-resistant, indicating that these molecules had 
failed to reach the medial and trans-Golgi cisternae where 
terminal modification of the carbohydrate takes place. This 
result suggests that the rate-limiting step in the secretion of 
the hGH-DAF28 fusion protein is passage into the medial 
Golgi complex. 
Colocalization of the hGH-DAF28 Fusion Protein with 
a Marker of the ER-Golgi Intermediate Compartment 
Newly synthesized proteins upon exiting the ER,  are be- 
lieved  to  pass  through  a  recently  identified intermediate 
compartment on their way to the Golgi apparatus (Saraste 
and Kuismanen, 1984; Lodish et al., 1987; Schweizer et al., 
1988).  This ER-Golgi intermediate compartment is defined 
by p53,  a  53-kD  nonglycosylated transmembrane protein 
present in a tubulo-vesicular membrane system close to the 
cis-side  of the  Golgi apparatus  (Schweizer  et  al.,  1988, 
1991), and possibly includes the cis-most stakes of the Golgi 
Apparatus  (Mellman and  Simons,  1992).  It has  recently 
been suggested that this compartment, which functions in 
receiving and sorting proteins delivered from the ER,  be 
known as the cis-Golgi  network (CGN) (Hsu et al.,  1991; 
Mellman and  Simons,  1992).  To determine whether this 
might be the structure in which the hGH-DAF28 molecules 
accumulate, we analyzed transfected cells by double label 
immunofluorescence, using an anti-p53  monoclonal anti- 
body together with rabbit anti-hGH IgG. Colocalization of 
both markers to the same juxtanuclear structure (Fig. 9), to- 
gether with the observation that the retained molecules re- 
main endo H-sensitive, is consistent with a conclusion that 
the uncleaved hGH-DAF28 fusion protein is retained in the 
CGN. 
Because the salvage of resident ER proteins by the KDEL 
receptor (Munro and Pelham,  1987) is thought to occur in 
the CGN (Pelham,  1988;  Warren,  1987; Mellman and Si- 
mons, 1992), we asked whether the 72-kD glycoprotein, one 
of two proteins postulated to be the KDEL receptor (Vaux 
et al., 1990),  colocalizes with hGH-DAF28 in the same jux- 
tanuclear structure. Double label immunofluorescence indi- 
cated that this is not the case (Fig. 9). An antibody to the 
72-kD KDEL receptor labeled a series of vesicles that occa- 
sionally showed partial  overlap  with  vesicles  containing 
hGH-DAF28. However,  the juxtanuclear structure that was 
intensely stained with anti-hGH IgG, was not labeled, sug- 
gesting that for the most part the two proteins are contained 
in different compartments or subcompartments. 
Discussion 
The Process of GPI Attachment 
Our observations indicate that the processing of hGH-DAF 
fusion proteins bearing a GPI signal is incomplete after over- 
expression in COS cells (Moran et al., 1991). A similar ob- 
servation has been made using alkaline phosphatase (Mica- 
novic et al.,  1990).  This suggests that the machinery for 
anchor attachment, or the availability of the preassembled 
anchor, is limiting. Our pulse-chase analysis indicates that 
hGH-DAF polypeptides that initially escape COOH-terminal 
processing and anchor attachment, never become GPI-an- 
chored proteins. As a possible explanation we suggest that 
GPI attachment occurs in the membrane during transloca- 
tion,  and  that  uncleaved  polypeptides become  separated 
from the processing machinery after extrusion into the lu- 
men of  the ER. It is tempting to speculate that the machinery 
for GPI attachment might be part of  a translocation complex 
that  includes  signal  peptidase,  oligosaccharyltransferase, 
glucosidases, and possibly proteins involved in folding. As- 
suming that the machinery for GPI attachment is limiting 
such that not all translocation sites are capable of  GPI attach- 
ment, the function of the hydrophobic component of the GPI 
signal might be to briefly retard exit from the membrane, 
thereby increasing the chance of an encounter with the pro- 
cessing activity. Our observation that the COOH-terminal 
hydrophobic domain of DAF slows secretion of hGH is con- 
sistent with this hypothesis. 
An Uncleaved GPI Signal Causes Retention 
hGH-DAF fusion proteins  containing substitutions at the 
cleavage site that prevent processing of the GPI signal, fail 
to be transported to the cell surface as judged by an absence 
of fusion protein in the culture medium or on the plasma 
membrane. Similarly, incompletely processed hGH-DAF37 
or hGH-DAF29 polypeptides, bearing a functional but un- 
cleaved GPI signal, are not transported to the cell surface. 
Intracellular accumulation of these uncleaved fusion pro- 
teins suggests the presence of a retention signal that prevents 
passage through the secretory pathway. These observations 
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localization  of hGH-DAF28 with 
either p53 or the 72-kD KDEL 
receptor. Transfected  COS cells 
grown on coverslips were fixed 
and permeabilized and treated 
with rabbit anti-hGH IgG and a 
mouse  monoclonal antibody 
against either p53 or the 72-kD 
KDEL receptor, followed  by flu- 
orescein-conjugated  anti-mouse 
and rhodamine-conjugated  anti- 
rabbit IgG. 
are  consistent with at least two possibilities:  (a)  the un- 
cleaved COOH-terminal extension induces misfolding and/or 
aggregation of the attached protein, resulting in retention; or 
(b) there is a retention signal associated with the uncleaved 
COOH-terminal  extension itself.  Although we  cannot at 
present distinguish between these two models, our results 
suggest that the structural requirements of a COOH-terminal 
extension causing retention, are somewhat similar to the re- 
quirements for GPI attachment itself.  The last 29  amino 
acids of DAF constitute the minimal DAF sequence that will 
signal  anchor  attachment (Moran  et  al.,  1991). The  17- 
residue COOH-terminal hydrophobic domain alone neither 
triggers anchor attachment (Caras et al.,  1989) nor causes 
retention; hGH-DAF17 (containing only the 17-residue hy- 
drophobic domain of DAF fused to the COOH terminus of 
hGH) is secreted, albeit more slowly than authentic hGH. 
A  COOH-terminal  extension  comprised  of  the  COOH- 
terminal hydrophobic domain combined with 10 or more 
of the adjacent DAF residues, containing either a partial or 
complete cleavage/attachment site, results in retention; un- 
cleaved hGH-DAF27 (Caras et al., 1989), hGH-DAF28, and 
hGH-DAF29 are all retained. In contrast, a fusion protein 
containing the COOH-terminal hydrophobic domain of  DAF 
plus an irrelevant 8-residue hydrophilic spacer, fused to the 
COOH-terminus of  hGH, fails to become GPI-anchored and 
is secreted (hGH-Synl7, Caras et al,, 1989). Consistent with 
our observations, mutations that block cleavage of the alka- 
line phosphatase GPI signal similarly block transport to the 
cell surface (Micanovic et al.,  1990),  indicating that this 
phenomenon is not specific to the DAF GPI-signal. 
N-Linked Glycosylation and Secretion 
In experiments using rat growth hormone (rGH), Guan and 
Rose (1984) showed that conversion of rGH to a membrane 
protein by the addition of the transmembrane-cytoplasmic 
domains  of  the  vesicular  stomatitis  virus  glycoprotein, 
prevented transport to the cell surface. The introduction of 
N-linked glycosylation reversed the secretion block and al- 
lowed membrane-attached rGH to reach the plasma mem- 
brane (Guan et al., 1985). The authors suggested that a sort- 
ing  signal  required  for  the  secretion  of  rGH  was  not 
functional when the molecule was bound to the membrane, 
and that N-linked glycosylation provided the missing signal 
for transport to the cell surface. Our data using hGH indicate 
that GPI-anchored hGH is efficiently transported to the cell 
surface (Caras et al., 1989; Moran et al., 1991), suggesting 
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vent secretion  of hGH,  or that the GPI-signal  facilitates 
transport to the plasma membrane.  The latter possibility is 
not unlikely in view of recent evidence that whereas trun- 
cated T-cell receptor chains fail to be secreted, GPI-linked 
chains are efficiently transported  to the cell surface (Lin et 
al., 1990). Our present results indicate that the addition of 
N-linked  glycosylation partially alleviates the intracellular 
retention  of uncleaved hGH-DAF28, but not hGH-DAF29, 
allowing a fraction of the unprocessed fusion protein to be 
secreted.  If retention is due to misfolding and/or aggrega- 
tion, induced by the uncleaved COOH-terminal  extension, 
we would have to assume that randomly introduced carbohy- 
drate facilitates correct folding, or prevents aggregation, of 
hGH-DAF28 but not hGH-DAF29 (these proteins differ only 
by the presence or absence of  a single Ser residue). Alterna- 
tively, if the uncleaved COOH-terminal  extension is recog- 
nized directly as a retention signal, N-linked glycosylation 
might in some way provide an opposing signal, resulting in 
partition. The presence of  a complete GPI signal with a func- 
tional cleavage/attachment site (as in hGH-DAF29)  might 
provide a stronger retention signal than a defective GPI sig- 
nal with a nonfunctional cleavage site (hGH-DAF28), result- 
ing in the failure of glycosylation to override the secretion 
block in the former case. 
Intracellular Localization of  the Retained hGH-DAF 
Fusion Proteins 
Immunofluorescent  staining  suggested that the uncleaved 
hGH-DAF fusion proteins are transported out of the ER and 
accumulate in a BFA sensitive structure that colocalizes with 
both a Golgi marker and with p53, a marker of the ER-Golgi 
intermediate  compartment.  The  retained  molecules  re- 
mained endo H-sensitive whereas molecules that escaped the 
transport block acquired resistance.  This suggests that the 
retained molecules do not reach the medial Golgi complex. 
Taken together, these observations argue that the uncleaved 
fusion protein accumulates in a compartment  intermediate 
between the ER and the medial Golgi complex.  Using the 
three compartment model of  the Golgi complex proposed by 
Hsu et al. (1991), Pelham (1991) and Mellman and Simons 
(1992) we propose  that the uncleaved fusion proteins  ac- 
cumulate in the CGN, which is comprised of the cis-most 
cisternae of the Golgi Apparatus  and the adjacent tubulo- 
vesicular structures known as the intermediate compartment 
(Mellman and Simons, 1992; Schweizer et al., 1988; Lewis 
et al.,  1990). The CGN is postulated to be a salvage com- 
partment in which proteins are selected for return to the ER 
(Warren, 1987; Pelham, 1991; Mellman and Simons, 1992). 
There is evidence suggesting that unassembled major histo- 
compatibility complex class I molecules that fail to be trans- 
ported to the cell surface, recycle between the ER and the 
CGN (Hsu et al., 1991). In view of  the postulated role of  this 
compartment  as a sorting compartment, we speculate that in- 
completely processed  precursors  to  GPI-linked  proteins 
progress  out of the ER and enter the CGN, where further 
transit into the medial Golgi complex is prevented by a quality 
control mechanism. As stated above, the uncleaved COOH- 
terminal extension might function as a retention  signal by 
driving aggregation or misfolding of the attached  protein. 
(Quality control mechanisms preventing the secretion of in- 
completely assembled  multisubunit  proteins  or misfolded 
proteins have been reviewed by Hurtley and Helenius, 1989; 
Klausner,  1989; Rose and Doms,  1988). Alternatively, it is 
possible that the uncleaved GPI-signal is recognized directly 
as a retention  signal,  in which case an additional editing 
function of the CGN might be the sorting and retention of 
improperly  processed precursors  to GPI-linked proteins. 
The KDEL receptor is believed to function in the retrieval 
of ER proteins from a post-ER  salvage compartment,  pre- 
sumably the CGN (Pelham,  1988, 1991; Mellman and Si- 
mons,  1992). Two different KDEL receptors have been de- 
scribed  (Vaux et al.,  1990; Lewis and Pelham,  1990). In 
transfected COS cells, the 26-kD KDEL receptor (Lewis and 
Pelham, 1990) was localized to a Golgi-like structure similar 
to that containing hGH-DAF28. However, our data indicate 
that in COS cells, the 72-kD KDEL receptor (Vaux et al., 
1990) is localized in a vesicular compartment distinct from 
the juxtanuclear structure containing uncleaved hGH-DAF- 
28. These observations may reflect the heterogeneous or dy- 
namic nature of the salvage compartment. 
Received for publication 6  March  1992 and in revised form 26 August 
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